HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 182 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,182,997 | -6.9% | 36,100 | 0.0% | 0.06% | +33.3% |
| Q2 2023 | $1,270,359 | +7.8% | 36,100 | 0.0% | 0.05% | +9.1% |
| Q1 2023 | $1,178,665 | -32.7% | 36,100 | +13.5% | 0.04% | -27.9% |
| Q4 2022 | $1,752,180 | +38.8% | 31,800 | +11.6% | 0.06% | +22.0% |
| Q3 2022 | $1,262,000 | -97.8% | 28,500 | -89.1% | 0.05% | -95.1% |
| Q2 2022 | $57,631,000 | +3734.4% | 261,693 | +746.9% | 1.01% | +2008.3% |
| Q1 2022 | $1,503,000 | +14.0% | 30,900 | 0.0% | 0.05% | +11.6% |
| Q4 2021 | $1,318,000 | +11.3% | 30,900 | 0.0% | 0.04% | +13.2% |
| Q3 2021 | $1,184,000 | +35.8% | 30,900 | 0.0% | 0.04% | +35.7% |
| Q2 2021 | $872,000 | – | 30,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
| venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
| Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
| Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
| ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
| TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
| MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
| O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |